Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas.
Gregor LaimerPeter SchullianYannick ScharllDaniel PutzerGernot EberleGeorg OberhuberReto BalePublished in: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group (2022)
Percutaneous thermal ablation is efficient in the treatment of HCAs and may thus be considered a valid first-line treatment option. In addition, SRFA allows for an effective, minimally invasive treatment of large and multiple hepatic tumors within one session.